Market Gems:Stocks w/Strong Earnings and High Tech. Rank Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jenna who wrote (13084)	8/17/1998 12:59:00 PM
From: Jenna	Read Replies (2) of 120523

Metra Biosystems (MTRA) Gets Approval For Osteoporosis Bone Test MOUNTAIN VIEW, Calif. -(Dow Jones)- Metra Biosystems Inc. said Monday it received Food and Drug Administration premarket approval for its Pyrilinks-D bone resorption immunoassay in the treatment of osteoporosis. Pyrilinks-D monitors patient response to hormone replacement therapy in the treatment and prevention of osteoporosis. Also, Metra Biosystems (MTRA) said United Kingdom retailer Superdrug launched Pyrilinks-D as an over-the-counter osteoporosis risk assessment test. Copyright (c) 1998 Dow Jones & Company, Inc. All Rights Reserved.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next